Eye

DC 6014

Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)

Educational use only. Not legal or medical advice. Read 38 CFR §4.79 on eCFR
Diagnostic Code
6014
CFR Section
§4.79 — Eye

Rating Tiers

100%

Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation

Rated Under Formula

This condition is rated using the §4.79 general rating formula.

60%

With documented incapacitating episodes requiring 7 or more treatment visits for an eye condition during the past 12 months

40%

With documented incapacitating episodes requiring at least 5 but less than 7 treatment visits for an eye condition during the past 12 months

20%

With documented incapacitating episodes requiring at least 3 but less than 5 treatment visits for an eye condition during the past 12 months

10%

With documented incapacitating episodes requiring at least 1 but less than 3 treatment visits for an eye condition during the past 12 months

What Raters Look For

Based on M21-1 adjudication criteria for Eye conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.F
  • •Best corrected visual acuity in each eye (Snellen chart results)
  • •Visual field test results — field of vision defects or scotomas
  • •Diplopia (double vision) — whether present in any field of gaze
  • •Intraocular pressure readings if glaucoma is involved
  • •Documented impact on daily activities, driving, and occupational function
Diagnostic Code 6014 — Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) | VA Rating Criteria